Obsidian Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$165M
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Obsidian Therapeutics's estimated annual revenue is currently $8.2M per year.(?)
  • Obsidian Therapeutics's estimated revenue per employee is $155,000
  • Obsidian Therapeutics's total funding is $165M.

Employee Data

  • Obsidian Therapeutics has 53 Employees.(?)
  • Obsidian Therapeutics grew their employee count by 51% last year.
  • Obsidian Therapeutics currently has 1 job openings.

Obsidian Therapeutics, founded in 2015, aspires to extend adoptive immunotherapy to every patient with cancer. We do this by building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients. We create adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs. With this unique approach, we can dramatically improve on the current generation of cell therapies. Headquartered in Cambridge, MA, Obsidian has assembled an industry-leading team of experts in immunology, cell therapy, and oncology. We continue to build our team so please check our website (www.obsidiantx.com) often for job opportunities.

keywords:Healthcare,Human Resources Hr,Pharmaceuticals